Biocompatibility of PEG-based hydrogels in primate brain

Area of Science:

• Biomaterials Science
• Neuroscience
• Immunology

Background:

• Degradable polymers are widely used in peripheral tissue regeneration and drug delivery.
• The brain's unique immune environment poses challenges for biomaterial compatibility.
• Polyethylene glycol (PEG)-based hydrogels are being explored for neural applications.

Purpose of the Study:

• To evaluate the biocompatibility of PEG-based hydrogels in the nonhuman primate brain.
• To assess the host immune response to implanted hydrogels over four months.
• To determine the potential of PEG hydrogels for neural tissue reconstruction and drug delivery.

Main Methods:

• PEG-based hydrogels (20% w/v) were implanted into the striatum and cerebral cortex of nonhuman primates.
• Brain tissue was analyzed after four months for astrogliosis, scarring, microglia/macrophage presence, and T-cell infiltration.
• Immunohistochemistry was used to quantify glial fibrillary acidic protein (GFAP), CD68, and CD3+ T cells.

Main Results:

• A slight, non-significant increase in astrocytic (GFAP) and microglial/macrophage (CD68) markers was observed compared to sham implants.
• No significant gliotic scarring or peripheral T-cell (CD3+) infiltration was detected.
• The immune response was comparable to the brain's natural state, indicating good tolerance.

Conclusions:

• PEG-based hydrogels demonstrate a low level of immune response in the primate brain.
• The observed response does not indicate immunorejection, suggesting good biocompatibility.
• PEG hydrogels hold promise for future applications in primate brain drug delivery and neural tissue regeneration.